ArchiveMerck Hikes Diabetes Exposure Via Acquisition (MRK, JNJ, DEPO, ARRY, MNKD, SPEX, BIOD, AMLN, GNBT, ALKS, LLY, ARNA)Posted by Jason Smith at 11:39AM on December 2nd
Pharmaceutical giant Merck (MRK) agreed to purchase Beverly, Massachusetts-based insulin maker SmartCells for as much as $500 million, boosting the firm’s exposure the diabetes segment, which generated $2.58 billion in 2009 revenue. Miller Tabak portfolio manager Les Funtleyder told Bloomberg, “We… Sharp Rebound for MannKind, Generex (GNBT, MNKD, SPEX, AMLN, NVO, ARRY)Posted by Jason Smith at 1:35PM on March 23rd
Shares of Valencia, California-based Mannkind Corp (MNKD) are rebounding sharply after two days of declines in a recent downtrend spurred by the FDA’s request for additional information related to the company’s Afrezza inhaled insulin. The stock remains off by -10% over… |
| Home | Find | Research | Track | Register | My Account | Logout | Web site design by LightMix |
| © 2007-2013 Indie research Corp. All rights reserved. |